Sun Meng

Dr. Sun Meng


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2024 in Medicine
Verified
Journal Article
Open access
JMJialin Mm Mu
Jialin Mm Mu
YLYulin Mm Li
Yulin Mm Li
SMSun Meng
Sun Meng
PLPanpan Li
Panpan Li
JWJingyun Mm Wang
Jingyun Mm Wang
HZHui Zou
Hui Zou
Rationale: The high clinical heterogeneity of hypermethioninemia caused by MAT1A gene defects has resulted in a paucity of studies examining the association between clinical phenotypes, biochemical characteristics, and gene mutations in this patient group. Furthermore, the indications for therapeutic interventions in patients remain unclear. The objective of this study is to provide a foundation for clinical diagnosis, genetic counseling, and follow-up management of hypermethioninemia caused by MAT1A gene defects. Patient concerns: A retrospective analysis of children with hypermethioninemia at Jinan Maternal and Child Health Hospital from January 2016 to December 2023 was performed using tandem mass spectrometry (MS/MS). The screened and diagnosed children were tested for gene mutations using second-generation sequencing technology and confirmed using Sanger sequencing. Diagnoses: Newborn MS/MS screening for diseases demonstrated an elevated methionine level, which was outside the reference range. Upon recalling the newborns, the methionine levels remained elevated, necessitating further refinement of genetic testing. Ultimately, genetic testing confirmed hypermethioninemia, which was attributed to a mutation in the MAT1A gene. Interventions: The intervention for the patients in this study took the following forms: regular follow-up without treatment (n = 3), intake of methionine-free milk powder without any medication (n = 4), intake of methionine-free milk powder with some medication, and eventually liver transplantation (n = 1). Outcomes: A total of 14 mutation types were detected, including 3 compound heterozygous mutation types (c.926G > T, c.37_38delCT, and c.316G > A) that have not been previously reported. One patient had monoheterozygous mutations, including the novel mutation c.550-1G > A. Eight cases were monitored over time, 7 of which demonstrated typical growth and development. One infant with growth retardation was fed a special formula lacking methionine. The patient underwent liver transplantation. Subsequent follow-up examinations showed methionine and homocysteine levels within normal limits and no further neurological manifestations. Lessons: Compound heterozygous mutations c.874C > T and c.896G > A may result in higher levels of methionine, affecting the central nervous system. For newborns with initial methionine levels of >500 µmol/L, treatment with a low-Met diet is recommended. Liver transplantation may be beneficial for children with severe hypermethioninemia, particularly in preventing central nervous system damage.

1 December 2023 in Journal of Zhejiang University (Medical Sciences)
Verified
Journal Article
Open access
SMSun Meng
Sun Meng
YLYulin Li
Yulin Li
PLPanpan Li
Panpan Li
GLGaijie Li
Gaijie Li
YYYan Yan
Yan Yan
HZHui Zou
Hui Zou
Objective To retrospectively analyze the variation characteristics of phenylalanine hydroxylase (PAH) gene, and to observe the long-term treatment effect and follow-up of newborns with PAH deficiency. Methods The clinical data, treatment and follow-up results of 198 children with PAH deficiency, which diagnosed by newborn screening in Jinan from 1996 to 2021 were collected. The genetic analysis results of 55 children with PAH deficiency diagnosed by newborn screening in Jinan and 213 children referred from the surrounding areas of Jinan were summarized. Gene mutations were checked by a customized Panel gene detection method. As also as blood phenylalanine-concentration, physical development indicators include height and weight were regularly monitored. Intellectual development was assessed using the neuropsychological development scale for children aged 0-6 years and academic performance, and brain injury in children was assessed using brain magnetic resonance imaging. Results c.728G>A, c.158G>A, c.721C>T, c.1068C>A, c.611A>G mutations were common in PAH gene. The genotype of c.158G>A mutation is compound heterozygous mutation, mainly mild hyperphenylalaninemia, but it is also found in both classic phenylketo-nuriaand mild phenylketonuria. 168 children with PAH deficiency who were followed up regularly had normal physical development without dwarfism or malnutrition.Among the 33 preschool children who underwent mental development assessment, 2 were mentally retarded and the initial treatment age was older than 6 months. Nine children with an average age of (17.13±2.42) years completed brain magnetic resonance imaging, 1 case was normal and 8 cases were abnormal. Brain magnetic resonance imaging results showed different differences. There were patchy or patchy hyperintense foci near the bilateral lateral ventricles on T2WI, and the intellectual development was normal. The blood phenylalanine concentration of one normal child was better and stably controlled within the ideal range than that of the other eight children. Conclusion c.728G>A, c.158G>A, c.721C>T, c.1068C>A, c.611A>G mutations were common in PAH gene. After standardized treatment, most children with PAH deficiency diagnosed by screening can obtain normal growth and intellectual development in adolescence, but there are different degrees of organic lesions in the cerebral white matter.